Aurora Cannabis Inc. closed 60.96% short of its 52-week high of $9.35, which the company reached on April 30th.

Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...

Aurora Cannabis Inc. closed 59.14% short of its 52-week high of $9.35, which the company achieved on April 30th.

Canadian producer Aurora Cannabis has delivered its first flower product in Germany’s growing medical marijuana market.

在其他近期新闻中,Aurora Cannabis Inc.报告了2025财年第二季度的强劲增长。公司净收入同比增长29%至8110万美元,而调整后EBITDA同比大幅增长210%至1010万美元。公司的医用大麻收入也有所增长,增长41%至6130万美元,其中国际销售增长93%。然而,消费类大麻净收入下降至1040万美元。

Discover the long-lasting effects of heavy cannabis use on brain function. Find out how marijuana can impact memory even ...

Trudeau's legalization legacy shaped Canada's global cannabis leadership. Conservative leadership risks policy stagnation & economic setbacks; publicly traded weed companies face uncertainty amid ...

A new study from the University of Colorado Anschutz Medical Campus suggests that heavy cannabis use negatively affects ...

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 4,520,000 shares, a growth of 5.9% ...